Cancer Research Center of Lyon (CRCL), Tumor Escape Resistance Immunity Department, INSERM-1052, CNRS 5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France.
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
Front Immunol. 2022 May 23;13:899104. doi: 10.3389/fimmu.2022.899104. eCollection 2022.
Bone loss associated with estrogen deficiency indicates a fundamental role of these hormones in skeletal growth and bone remodeling. In the last decades, growing recent evidence demonstrated that estrogens can also affect the immune compartment of the bone. In this review, we summarize the impacts of estrogens on bone immune cells and their consequences on bone homeostasis, metastasis settlement into the bone and tumor progression. We also addressed the role of an orphan nuclear receptor ERRalpha ("Estrogen-receptor Related Receptor alpha") on macrophages and T lymphocytes, and as an immunomodulator in bone metastases. Hence, this review links estrogens to bone immune cells in osteo-oncology.
与雌激素缺乏相关的骨质流失表明这些激素在骨骼生长和骨重塑中起着根本作用。在过去的几十年中,越来越多的新证据表明,雌激素也可以影响骨骼的免疫区室。在这篇综述中,我们总结了雌激素对骨免疫细胞的影响及其对骨内稳态、转移到骨和肿瘤进展的影响。我们还讨论了孤儿核受体 ERRalpha(“雌激素受体相关受体 alpha”)在巨噬细胞和 T 淋巴细胞中的作用,以及作为骨转移中的免疫调节剂。因此,这篇综述将雌激素与骨肿瘤学中的骨免疫细胞联系起来。